195
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Clinical Characteristics and Medical Utilization of Smokers with Preserved Ratio Impaired Spirometry

, ORCID Icon, , ORCID Icon, ORCID Icon, & ORCID Icon show all
Pages 2187-2194 | Received 02 Aug 2023, Accepted 01 Oct 2023, Published online: 06 Oct 2023

References

  • Agustí A, Celli BR, Criner GJ, et al. Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary. Eur Respir J. 2023;61(4):2300329. doi:10.1183/13993003.00239-2023
  • Guerra S, Sherrill DL, Venker C, Ceccato CM, Halonen M, Martinez FD. Morbidity and mortality associated with the restrictive spirometric pattern: a longitudinal study. Thorax. 2010;65(6):499–504. doi:10.1136/thx.2009.126052
  • Iyer VN, Schroeder DR, Parker KO, Hyatt RE, Scanlon PD. The nonspecific pulmonary function test: longitudinal follow-up and outcomes. Chest. 2011;139(4):878–886. doi:10.1378/chest.10-0804
  • Wan ES, Castaldi PJ, Cho MH, et al. for COPDGene Investigators. Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene. Respir Res. 2014;15(1):89. doi:10.1186/s12931-014-0089-y
  • Backman H, Eriksson B, Hedman L, et al. Restrictive spirometric pattern in the general adult population: methods of defining the condition and consequences on prevalence. Respir Med. 2016;120:116–123. doi:10.1016/j.rmed.2016.10.005
  • Wan ES, Fortis S, Regan EA, et al. for COPDGene Investigators. Longitudinal phenotypes and mortality in preserved ratio impaired spirometry in the COPDGene study. Am J Respir Crit Care Med. 2018;198(11):1397–1405. doi:10.1164/rccm.201804-0663OC
  • Marott JL, Ingebrigtsen TS, Çolak Y, Vestbo J, Lange P. Trajectory of preserved ratio impaired spirometry: natural history and long-term prognosis. Am J Respir Crit Care Med. 2021;204(8):910–920. doi:10.1164/rccm.202102-0517OC
  • Kim J, Lee C-H, Lee HY, Kim H. Association between comorbidities and preserved ratio impaired spirometry: using the Korean national health and nutrition examination survey IV–VI. Respiration. 2022;101(1):25–33. doi:10.1159/000517599
  • Higbee DH, Granell R, Smith GD, Dodd JW. Prevalence, risk factors, and clinical implications of preserved ratio impaired spirometry: a UK Biobank cohort analysis. Lancet Respir Med. 2022;10(2):149–157. doi:10.1016/S2213-2600(21)00369-6
  • Vaz Fragoso CA, McAvay G, Van Ness PH, et al. Phenotype of spirometric impairment in an aging population. Am J Respir Crit Care Med. 2016;193(7):727–735. doi:10.1164/rccm.201508-1603OC
  • Guerra S, Carsin A-E, Keidel D, et al. Health-related quality of life and risk factors associated with spirometric restriction. Eur Respir J. 2017;49(5):1602096. doi:10.1183/13993003.02096-2016
  • Heo IR, Kim HC, Kim T-H. Health-related quality of life and related factors in persons with preserved ratio impaired spirometry: data from the Korea National Health and nutrition examination Surve. Medicina. 2020;57(1):4. doi:10.3390/medicina57010004
  • Kweon S, Kim Y, Jang M-J, et al. Data resource profile: the Korea national health and nutrition examination survey (KNHANES). Int J Epidemiol. 2014;43(1):69–77. doi:10.1093/ije/dyt228
  • Celli BR, MacNee W, Agusti A; for ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23(6):932–946. doi:10.1183/09031936.04.00014304
  • Haynes W; Bonferroni Correction. Encyclopedia of Systems Biology. New York: Springer; 2013:154.
  • Wan ES, Balte P, Schwartz JE, et al. Association between preserved ratio impaired spirometry and clinical outcomes in US adults. JAMA. 2021;326(22):2287–2298. doi:10.1001/jama.2021.20939
  • Washio Y, Sakata S, Fukuyama S, et al. Risks of mortality and airflow limitation in Japanese with preserved ratio impaired spirometry. Am J Respir Crit Care Med. 2022;206(5):563–572. doi:10.1164/rccm.202110-2302OC
  • Creutzberg EC, Wouters EF, Vanderhoven-Augustin IM, Dentener MA, Schols AM. Disturbances in leptin metabolism are related to energy imbalance during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;162(4 Pt 1):1239–1245. doi:10.1164/ajrccm.162.4.9912016
  • Claycombe K, King LE, Fraker PJ. A role for leptin in sustaining lymphopoiesis and myelopoiesis. Proc Natl Acad Sci USA. 2008;105(6):2017–2021. doi:10.1073/pnas.0712053105
  • Mancuso P, Canetti C, Gottschalk A, Tithof PK, Peters-Golden M. Leptin augments alveolar macrophage leukotriene synthesis by increasing phospholipase activity and enhancing group IVC iPLA2 (cPLA2γ) protein expression. Am J Physiol Lung Cell Mol Physiol. 2004;287(3):L497–L502. doi:10.1152/ajplung.00010.2004
  • Dixon AE, Johnson SE, Griffes LV, et al. Relationship of adipokines with immune response and lung function in obese asthmatic and non-asthmatic women. J Asthma. 2011;48(8):811–817. doi:10.3109/02770903.2011.613507
  • Simmons MS, Connett JE, Nides MA, et al. Smoking reduction and the rate of decline in FEV1: results from the Lung Health Study. Eur Respir J. 2005;25(6):1011–1017. doi:10.1183/09031936.05.00086804
  • Parekh TM, Bhatia S, Cherrington A, et al. Factors influencing decline in quality of life in smokers without airflow obstruction: the COPDGene study. Respir Med. 2020;161:105820. doi:10.1016/j.rmed.2019.105820
  • Siddharthan T, Grigsby M, Miele CH, et al. Prevalence and risk factors of restrictive spirometry in a cohort of Peruvian adults. Int J Tuberc Lung Dis. 2017;21(9):1062–1068. doi:10.5588/ijtld.17.0101
  • Park HJ, Rhee CK, Yoo KH, Park YB. Reliability of portable spirometry performed in the Korea national health and nutrition examination survey compared to conventional spirometry. Tuberc Respir Dis. 2021;84(4):274–281. doi:10.4046/trd.2021.0016
  • Stanojevic S, Kaminsky DA, Miller MR, et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J. 2022;60(1):2101499. doi:10.1183/13993003.01499-2021
  • Oh DK, Baek S, Lee SW, Lee JS, Lee S-D, Oh Y-M. Comparison of the fixed ratio and the Z-score of FEV1/FVC in the elderly population: a long-term mortality analysis from the third national health and nutrition examination survey. Int J Chron Obstruct Pulmon Dis. 2018;13:903–915. doi:10.2147/COPD.S148421
  • Kaise T, Sakihara E, Tamaki K, et al. Prevalence and characteristics of individuals with preserved ratio impaired spirometry (PRISm) and/or impaired lung function in Japan: the OCEAN study. Int J Chron Obstruct Pulmon Dis. 2021;16:2665–2675. doi:10.2147/COPD.S322041